SLC5A1 and cardiomyopathy: In this study, we first established that cardiomyocyte-specific knockdown of SGLT1 attenuates cardiomyopathy in vivo in mice fed a high fat diet (HFD) and attenuates ROS production in vitro in cardiomyocytes exposed to high glucose and insulin.